Sessioni Poster

CARDIOVASCULAR PHARMACOLOGY

26/10/2017 / 19.00 - 21.00
2Carbaprostacyclin prevents venous thrombosis in COX-2 KO mice: the new role of monocytes
1)Sandrini L.. 2)Tarantino E.. 3)Tremoli E.. 4)Barbieri SS.
20Apolipoprotein E modulates adaptive immune response by promoting cellular cholesterol metabolism
1)Bonacina F.. 2)Coe D.. 3)Wang G.. 4)Baragetti A.. 5)Garlaschelli K.. 6)Pellegatta F.. 7)Grigore L.. 8)Catapano A.. 9)Marelli-berg F.. 10)Norata D..
44Fluoroscopy-associated oxidative stress and cellular damage in patients with atrial fibrillation or ventricular arrhythmias undergoing transcatheter ablation: prevention by N-acetylcysteine pre-treatment.
1)Di minno A. 2)Casella M. 3)Russo E. 4)Ribatti V. 5)Turnu L. 6)Porro B. 7)Manega CM. 8)Cavalca V. 9)Tremoli E.
57LIPIDOMICS OF EICOSANOIDS GENERATED BY THE CROSS-TALK BETWEEN PLATELETS AND CANCER CELLS: MODULATION BY CYCLOOXYGENASE INHIBITORS
1)Grande R. 2)Schiavone S. 3)Dovizio M. 4)Tacconelli S. 5)Fullone R. 6)Hinz C. 7)O'Donnell V. 8)Patrignani P.
74Recombinant LCAT rescues defective HDL mediated endothelial protection in acute coronary syndrome
1)Ossoli A. 2)Simonelli S. 3)Varrenti M. 4)Morici N. 5)Oliva F. 6)Stucchi M. 7)Gomaraschi M. 8)Arnaboldi L. 9)Corsini A. 10)Veglia F. 11)Karathanasis S. 12)Franceschini G. 13)Calabresi L.
99Environmental Chronic Stress Induces Abnormal Megakaryopoiesis Predisposing to Thrombosis: Protective Effects of Apocynin.
1)Sandrini L. 2)Ieraci A. 3)Amadio P. 4)Popoli M. 5)Tremoli E. 6)Barbieri SS.
108THE H2S-DONOR, 4-CPI, PROMOTES ANTI-ISCHEMIC EFFECTS THROUGH ACTIVATION OF CARDIAC MITOKATP AND REDUCTION OF OXIDATIVE STRESS.
1)Testai L.. 2)Brancaleone V.. 3)Breschi M.. 4)Bucci M.. 5)Cirino G.. 6)Citi V.. 7)Gargini M.. 8)Martelli A.. 9)Piano I.. 10)Calderone V..
130Targeting platelet purinergic signalling as a potential therapeutic approach for cancer
1)Ballerini P. 2)Grande R. 3)Dovizio M. 4)Guillem-llobat P. 5)Petragnani N. 6)Patrignani P.
135Proatherosclerotic effect of trimethylamine-N-Oxyde: in vitro preliminary evidences
1)Battista S. 2)Mele L. 3)Adamo A. 4)De francesco R. 5)Aragones G. 6)Bernini F. 7)Del rio D. 8)Zanotti I.
149G-protein coupled estrogen receptor (GPER) and phosphofructokinase-2/fructose-2,6-bisphosphatase 3 (PFKFB3) are involved in estrogen-mediated angiogenesis
1)Boscaro C. 2)Trenti A. 3)Tedesco S. 4)Ferri N. 5)Trevisi L. 6)Bolego C. 7)Cignarella A.
162STATIN THERAPY: CLC-1 CHLORIDE CHANNEL AS A BIOLOGICAL MARKER OF MYOPATHY IN HUMANS
1)Camerino GM. 2)Musumeci O. 3)Conte E. 4)Barca E. 5)Toscano A. 6)Pierno S.
177Impaired glucose and lipid metabolism affects mitochondrial function in experimental diabetes-induced cardiac remodelling: role of MMP-2
1)Gliozzi M. 2)Scarano F. 3)Saverio N. 4)Scicchitano M. 5)Musolino V. 6)Carresi C. 7)Maiuolo J. 8)Maretta A. 9)Muscoli C. 10)Mollace V.
178BERGAMOT POLYPHENOLS PROTECT AGAINST DOXORUBICIN-INDUCED CARDIOMYOPATHY REDUCING ROS PRODUCTION AND PROMOTING MYOCYTE SURVIVAL
1)Carresi C. 2)Musolino V. 3)Gliozzi M. 4)Giancotta C. 5)Scarano F. 6)Oppedisano F. 7)Paone S. 8)Palma E. 9)Muscoli C. 10)Mollace V.
193Ranolazine attenuates adverse myocardial remodeling, lung capillaries and endothelial dysfunction in a model of heart failure with preserved ejection fraction
1)Ciuffreda LP. 2)De angelis A. 3)Cappetta D. 4)Esposito G. 5)Piegari E. 6)Urbanek K. 7)Rossi F. 8)Berrino L.
243IN VITRO CARDIOVASCULAR TOXICITY RISK ASSESSMENT OF NOVEL H2S-DONATING ANTHRACYCLINE
1)Durante M. 2)Frosini M. 3)Fusi F. 4)Riganti C. 5)Gazzano E. 6)Chegaev K. 7)Saponara S.
277S1PR1, S1PR3 and FTY720 in vascular tone and blood pressure regulation
1)Gargiulo A.. 2)Cantalupo A.. 3)Dautaj E.. 4)Liu C.. 5)Zhang Y.. 6)Hla T.. 7)Bucci M.. 8)Di lorenzo A..
2973-Mercaptopyruvate relaxes aorta ring with a non enzymatic mechanism
1)Gurgone D.. 2)Mitidieri E.. 3)Tramontano T.. 4)Donnarumma E.. 5)Citi V.. 6)Calderone V.. 7)Nagahara N.. 8)Papapetropoulos A.. 9)Cirino G.. 10)D'emmanuele di villa bianca R.. 11)Sorrentino R..
333Vitamin D replacement in pre-menopausal women ameliorates cholesterol-related serum lipoprotein functions, adipokines profile and vascular markers of subclinical atherosclerosis
1)Marchi C. 2)Greco D. 3)Kocyigit D. 4)Adorni MP. 5)Ronda N. 6)Bernini F. 7)Gurses KM. 8)Oguz SH. 9)Gurlek A. 10)Tokgözoglu L. 11)Zimetti F.
356Sildenafil improves cardiac function in a rat model of cancer cachexia
1)Musolino MV. 2)Carresi CC. 3)Gliozzi GM. 4)Bosco BF. 5)Nucera NS. 6)Giancotta GC. 7)Tavano TD. 8)Scarano SF. 9)Scicchitano SM. 10)Maiuolo MJ. 11)Maretta MA. 12)Oppedisano OF. 13)Palma PE. 14)Muscoli MC. 15)Mollace MV.
357POTENTIAL MECHANISMS LINKING DEFECTS IN METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) AND CRYPTOGENIC STROKE PREDISPOSITION. A PRELIMINARY STUDY.
1)Nacci C. 2)Potenza MA. 3)Sgarra L. 4)Acquaviva T. 5)De cillis E. 6)Bortone AS. 7)Montagnani M.
374CARDIOTOXIC EFFECTS OF SHORT-TERM DOXORUBICIN ADMINISTRATION: INVOLVEMENT OF CONNEXIN 43 IN CALCIUM IMPAIRMENT.
1)Pecoraro M. 2)Ciccarelli M. 3)Iaccarino G. 4)Pinto A. 5)Popolo A.
388CM554, A NEW POTENT AND SELECTIVE INOS INHIBITOR: SYNTHESIS, DOCKING STUDY, AND EX VIVO BIOLOGICAL EVALUATION.
1)Potenza MA. 2)Macallini C. 3)Di matteo M. 4)Gallorini M. 5)Ammazzalorso A. 6)De filippis B. 7)Re N. 8)Graziani V. 9)Di silvestre S. 10)Fantacuzzi ML. 11)Giampietro L. 12)Pandolfi A. 13)Cataldi A. 14)Amoroso R. 15)Montagnani M.
389INTERMITTENT ANTAGONISM OF BK2-RECEPTOR TRIGGERS THE MOST EFFECTIVE KININ-DEPENDENT POSTCONDITIONING.
1)Potenza MA. 2)Sgarra L. 3)Leo V. 4)Nacci C. 5)De salvia MA. 6)Montagnani M.
415HYPERCHOLESTEROLEMIA MODULATES MITOCHONDRIAL DYSFUNCTION IN RAT DIABETIC CARDIOMYOPATHY
1) Scarano F.. 2)Gliozzi M.. 3)Musolino V.. 4)Carresi C.. 5)Nucera S.. 6)Scicchitano M.. 7)Maiuolo J.. 8)Maretta A.. 9)Bosco F.. 10)Giancotta C.. 11)Oppedisano F.. 12)Tavano D.. 13)Palma E.. 14)Muscoli C.. 15)Mollace V..
432Anti-angiogenic effect of therapeutic concentrations of digitoxin
1)Trenti A. 2)Zulato E. 3)Pasqualini L. 4)Indraccolo S. 5)Bolego C. 6)Trevisi L.
433Effects of digitoxin on cell migration in the ovarian cancer microenvironment
1)Trenti A. 2)Boscaro C. 3)Tedesco S. 4)Cignarella A. 5)Trevisi L. 6)Bolego C.
436PHARMACOLOGICAL MODULATION OF CARDIAC QT INTERVAL PROLONGATION THROUGH ALR2 SELECTIVE INHIBITION
1)Trotta MC. 2)Maisto R. 3)D'amico M. 4)Di filippo C.